Literature DB >> 26825533

IgA Structure Variations Associate with Immune Stimulations and IgA Mesangial Deposition.

Zeliha Oruc1, Christelle Oblet1, Ahmed Boumediene1, Anne Druilhe1, Virginie Pascal1, Elisabeth Le Rumeur2, Armelle Cuvillier3, Chahrazed El Hamel1, Sandrine Lecardeur1, Tomas Leanderson4, Willy Morelle5, Jocelyne Demengeot6, Jean-Claude Aldigier1, Michel Cogné7.   

Abstract

IgA1 mesangial deposition is the hallmark of IgA nephropathy and Henoch-Schönlein purpura, the onset of which often follows infections. Deposited IgA has been reported as polymeric, J chain associated, and often, hypogalactosylated but with no information concerning the influence of the IgA repertoire or the link between immune stimuli and IgA structure. We explored these issues in the α1KI mouse model, which produces polyclonal human IgA1 prone to mesangial deposition. Compared with mice challenged by a conventional environment, mice in a specific pathogen-free environment had less IgA deposition. However, serum IgA of specific pathogen-free mice showed more galactosylation and much lower polymerization. Notably, wild-type, α1KI, and even J chain-deficient mice showed increased polymeric serum IgA on exposure to pathogens. Strict germfree conditions delayed but did not completely prevent deposition; mice housed in these conditions had very low serum IgA levels and produced essentially monomeric IgA. Finally, comparing monoclonal IgA1 that had different variable regions and mesangial deposition patterns indicated that, independently of glycosylation and polymerization, deposition might also depend on IgA carrying specific variable domains. Together with IgA quantities and constant region post-translational modifications, repertoire changes during immune responses might, thus, modulate IgA propensity to deposition. These IgA features are not associated with circulating immune complexes and C3 deposition and are more pertinent to an initial IgA deposition step preceding overt clinical symptoms in patients.
Copyright © 2016 by the American Society of Nephrology.

Entities:  

Keywords:  IgA; IgA deposition; IgA nephropathy; Immunology and pathology; transgenic mouse

Mesh:

Substances:

Year:  2016        PMID: 26825533      PMCID: PMC5004660          DOI: 10.1681/ASN.2015080911

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  47 in total

1.  Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy.

Authors:  Ali G Gharavi; Zina Moldoveanu; Robert J Wyatt; Catherine V Barker; Susan Y Woodford; Richard P Lifton; Jiri Mestecky; Jan Novak; Bruce A Julian
Journal:  J Am Soc Nephrol       Date:  2008-02-13       Impact factor: 10.121

2.  IgA nephropathy at two score and one.

Authors:  Rosanna Coppo; John Feehally; Richard J Glassock
Journal:  Kidney Int       Date:  2009-11-18       Impact factor: 10.612

Review 3.  Glycosylation of IgA1 and pathogenesis of IgA nephropathy.

Authors:  Jan Novak; Bruce A Julian; Jiri Mestecky; Matthew B Renfrow
Journal:  Semin Immunopathol       Date:  2012-03-21       Impact factor: 9.623

4.  Spontaneous glomerular IgA deposition in ddY mice: an animal model of IgA nephritis.

Authors:  H Imai; Y Nakamoto; K Asakura; K Miki; T Yasuda; A B Miura
Journal:  Kidney Int       Date:  1985-05       Impact factor: 10.612

5.  Charge-dependent binding of polymeric IgA1 to human mesangial cells in IgA nephropathy.

Authors:  J C Leung; S C Tang; M F Lam; T M Chan; K N Lai
Journal:  Kidney Int       Date:  2001-01       Impact factor: 10.612

6.  Gammopathy with IgA mesangial deposition provides a monoclonal model of IgA nephritogenicity and offers new insights into its molecular mechanisms.

Authors:  Ahmed Boumediene; Christelle Oblet; Zeliha Oruc; Sophie Duchez; Willy Morelle; Anne Huynh; Jacques Pourrat; Jean-Claude Aldigier; Michel Cogné
Journal:  Nephrol Dial Transplant       Date:  2011-03-31       Impact factor: 5.992

7.  A mouse model recapitulating human monoclonal heavy chain deposition disease evidences the relevance of proteasome inhibitor therapy.

Authors:  Amélie Bonaud; Sébastien Bender; Guy Touchard; Corinne Lacombe; Nivine Srour; Laurent Delpy; Christelle Oblet; Anne Druilhe; Nathalie Quellard; Vincent Javaugue; Michel Cogné; Frank Bridoux; Christophe Sirac
Journal:  Blood       Date:  2015-06-25       Impact factor: 22.113

Review 8.  Dietary antigens and primary immunoglobulin A nephropathy.

Authors:  R Coppo; A Amore; D Roccatello
Journal:  J Am Soc Nephrol       Date:  1992-04       Impact factor: 10.121

Review 9.  Analysis of N- and O-linked glycans from glycoproteins using MALDI-TOF mass spectrometry.

Authors:  Willy Morelle; Valegh Faid; Frédéric Chirat; Jean-Claude Michalski
Journal:  Methods Mol Biol       Date:  2009

10.  A Two-amino Acid Mutation Encountered in Duchenne Muscular Dystrophy Decreases Stability of the Rod Domain 23 (R23) Spectrin-like Repeat of Dystrophin.

Authors:  Sébastien Legardinier; Baptiste Legrand; Céline Raguénès-Nicol; Arnaud Bondon; Serge Hardy; Christophe Tascon; Elisabeth Le Rumeur; Jean-François Hubert
Journal:  J Biol Chem       Date:  2009-01-20       Impact factor: 5.157

View more
  9 in total

1.  Mesangial Deposition Can Strongly Involve Innate-Like IgA Molecules Lacking Affinity Maturation.

Authors:  Batoul Wehbi; Christelle Oblet; François Boyer; Arnaud Huard; Anne Druilhe; François Paraf; Etienne Cogné; Jeanne Moreau; Yolla El Makhour; Bassam Badran; Marjolein Van Egmond; Michel Cogné; Jean-Claude Aldigier
Journal:  J Am Soc Nephrol       Date:  2019-06-21       Impact factor: 10.121

2.  Renal deposition and clearance of recombinant poly-IgA complexes in a model of IgA nephropathy.

Authors:  Xinfang Xie; Pan Liu; Li Gao; Xue Zhang; Ping Lan; Vanesa Bijol; Jicheng Lv; Hong Zhang; Jing Jin
Journal:  J Pathol       Date:  2021-04-09       Impact factor: 7.996

3.  microRNA-630 Regulates Underglycosylated IgA1 Production in the Tonsils by Targeting TLR4 in IgA Nephropathy.

Authors:  Chan Liu; Mu-Yao Ye; Wen-Zhe Yan; Xiao-Fei Peng; Li-Yu He; You-Ming Peng
Journal:  Front Immunol       Date:  2020-11-26       Impact factor: 7.561

4.  IgA nephropathy suspected to be combined with Fabry disease or Alport syndrome: a case report.

Authors:  Wen Hao; Lina Ao; Chenli Zhang; Lei Zhu; Deqiong Xie
Journal:  J Int Med Res       Date:  2019-12-16       Impact factor: 1.671

5.  Fecal Microbiota Transplantation Modulates Renal Phenotype in the Humanized Mouse Model of IgA Nephropathy.

Authors:  Gabriella Lauriero; Lilia Abbad; Mirco Vacca; Giuseppe Celano; Jonathan M Chemouny; Maria Calasso; Laureline Berthelot; Loreto Gesualdo; Maria De Angelis; Renato C Monteiro
Journal:  Front Immunol       Date:  2021-10-12       Impact factor: 7.561

Review 6.  Is There a Role for Gut Microbiome Dysbiosis in IgA Nephropathy?

Authors:  Renato C Monteiro; Dina Rafeh; Patrick J Gleeson
Journal:  Microorganisms       Date:  2022-03-22

Review 7.  Are there animal models of IgA nephropathy?

Authors:  Renato C Monteiro; Yusuke Suzuki
Journal:  Semin Immunopathol       Date:  2021-07-07       Impact factor: 9.623

8.  Aberrant mucosal immunoreaction to tonsillar microbiota in immunoglobulin A nephropathy.

Authors:  Hiroki Yamaguchi; Shin Goto; Nao Takahashi; Masafumi Tsuchida; Hirofumi Watanabe; Suguru Yamamoto; Yoshikatsu Kaneko; Koichi Higashi; Hiroshi Mori; Yukio Nakamura; Arata Horii; Ken Kurokawa; Ichiei Narita
Journal:  Nephrol Dial Transplant       Date:  2021-01-01       Impact factor: 5.992

Review 9.  How will artificial intelligence and bioinformatics change our understanding of IgA Nephropathy in the next decade?

Authors:  Roman David Bülow; Daniel Dimitrov; Peter Boor; Julio Saez-Rodriguez
Journal:  Semin Immunopathol       Date:  2021-04-09       Impact factor: 9.623

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.